Price$28.05-1.34 (-4.54%)
01:30 PM07:45 PM
News · 26 weeks1070%
2026-04-192026-10-11
Mix4690d
- Insider30(65%)
- Other9(20%)
- SEC Filings3(7%)
- Earnings2(4%)
- Analyst1(2%)
- Leadership1(2%)
Latest news
25 items- INSIDERSEC Form 4 filed by Hims & Hers Health Inc.4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERSEC Form 3 filed by Hims & Hers Health Inc.3 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- PRHims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading global health and wellness platform, today announced that it will report third quarter 2026 financial results after the market closes on Monday, November 9, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (833) 461-5787 for U.S. participants and (585) 542-9983 for international participants, referencing meeting ID 461 746 058. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. About Hims & Hers Health, Inc. Hims & Hers is the leading global health and wellness platf
- PRHers Launches in Australia, Built to Care for the Whole WomanJuniper becomes Hers, bringing new treatments spanning hair regrowth, menopause and perimenopause, and comprehensive weight management Hims & Hers, the leading global health and wellness platform, today announced the official launch of Hers in Australia, bringing its personalised care platform to women nationwide for the first time. The launch introduces first-of-their-kind treatment programs across Hair, Menopause and Perimenopause, and Weight Loss care - backed by women's-only research and 24/7 Care Team access. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261012999242/en/Juniper becomes Hers, bringing new treatments spann
- SECSEC Form 8-K filed by Hims & Hers Health Inc.8-K - Hims & Hers Health, Inc. (0001773751) (Filer)
- PRHims & Hers Names Jon Franklin as Chief Accounting OfficerCertified Public Accountant and former Rivian corporate controller will lead Hims & Hers accounting organization as the company expands into new specialties and global markets Hims & Hers Health, Inc. (NYSE:HIMS), the leading global health and wellness platform, today announced Jon Franklin has joined the company as Chief Accounting Officer. Franklin, a CPA with two decades of technical accounting experience across public accounting and corporate controllership, will oversee the company’s accounting organization, reporting to Chief Financial Officer Yemi Okupe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261007133997/en/Cer
- INSIDERChief Financial Officer Okupe Oluyemi sold $59,400 worth of shares (2,000 units at $29.70) as part of a pre-agreed trading plan, decreasing direct ownership by 0.85% to 234,527 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Legal Officer Boughton Soleil sold $100,957 worth of shares (3,461 units at $29.17) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 300,809 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- PRHims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical LeadershipKultar Garcha, MD, joins as Chief Medical Officer of the UK and EMEA, and Matt Vickers, FRACGP, MBBS, BMedSci, AICGG, is named Chief Medical Officer of Hims Australia, guiding clinical strategy as Hims & Hers continues to expand internationally Hims & Hers Health, Inc. (NYSE:HIMS), the leading global health and wellness platform, today announced two new clinical experts will join its global medical leadership team, led by Global Chief Medical Officer Pat Carroll, MD. Kultar Garcha, MD, will serve as Chief Medical Officer of the UK and EMEA, and Matt Vickers, FRACGP, MBBS, BMedSci, AICGG, will serve as Chief Medical Officer of Hims Australia. The appointments mark the company’s latest step
- INSIDERChief Financial Officer Okupe Oluyemi sold $876,846 worth of shares (29,277 units at $29.95) as part of a pre-agreed trading plan and exercised 14,000 shares at a strike of $5.01, decreasing direct ownership by 6% to 236,527 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Financial Officer Okupe Oluyemi sold $354,861 worth of shares (12,313 units at $28.82) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 251,804 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Legal Officer Boughton Soleil sold $173,735 worth of shares (6,236 units at $27.86) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 304,270 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Operating Officer Chi Michael sold $398,227 worth of shares (14,027 units at $28.39) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 456,660 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERCTO Elshenawy Mohamed sold $225,814 worth of shares (7,954 units at $28.39) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 185,556 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- ANALYSTAnalyst resumed coverage on Hims & Hers Health with a new price targetAnalyst resumed coverage of Hims & Hers Health with a rating of Neutral and set a new price target of $32.00
- INSIDERSEC Form 4 filed by Hims & Hers Health Inc.4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- PRHims Enters Australia, Marking First Expansion into the Asia-Pacific MarketWith the rebrand of Pilot, Eucalyptus' men's health platform, Hims enters a new market, supporting its path to $1 billion in international annual revenue within the next three years Hims & Hers Health, Inc. (NYSE:HIMS), the leading global health and wellness platform, today announced it is now serving customers in Australia, marking the company's first-ever presence in the Asia-Pacific market. The entry follows Hims & Hers' acquisition of Eucalyptus earlier this year and begins with the rebrand of Pilot, Eucalyptus' men's health platform, marking the first Eucalyptus brand to transition to the Hims brand. This press release features multimedia. View the full release here: https://www.bus
- PRHims Arrives in Australia, Bringing Personalised Care for Men NationwidePilot becomes Hims, bringing innovative, personalised care to help Australian men manage sexual health, weight loss, and hair loss Hims & Hers, the leading global health and wellness platform, today announced it is officially launching the Hims brand in Australia and bringing its personalised care platform to men nationwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260831313760/en/ The entry follows Hims & Hers' acquisition of Eucalyptus earlier this year and begins with the rebrand of Pilot, Eucalyptus' men's health platform. Effective today, Pilot becomes Hims. Patients will maintain the treatment plans and provider re
- PRBerger Montague PC Investigates Hims & Hers Health, Inc.’s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)PHILADELPHIA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces an investigation into the Board of Directors of Hims & Hers Health, Inc. (NYSE:HIMS) ("Hims & Hers" or the "Company") for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigation is focused on whether the Company improperly shared private user health data with advertisers, engaged in deceptive billing practices, and made subscription cancellations unnecessarily difficult. Hims & Hers, headquartered in San Francisco, Calif., is a digital health platform that connects individuals with licensed healthcare providers and, when appropriate, persona
- INSIDERChief Executive Officer Dudum Andrew gifted 463,289 shares and disposed of 977,566 shares (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Policy Officer Autor Deborah M. sold $467,128 worth of shares (16,773 units at $27.85) as part of a pre-agreed trading plan, decreasing direct ownership by 26% to 48,961 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Financial Officer Okupe Oluyemi sold $148,111 worth of shares (4,938 units at $29.99) as part of a pre-agreed trading plan and exercised 4,938 shares at a strike of $5.01 (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Legal Officer Boughton Soleil sold $691,808 worth of shares (25,111 units at $27.55) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 313,964 units (SEC Form 4)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Legal Officer Boughton Soleil converted options into 42,261 shares and covered exercise/tax liability with 21,500 shares, increasing direct ownership by 7% to 339,075 units (SEC Form 4) to satisfy tax liability4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
- INSIDERChief Medical Officer Carroll Patrick Harrison converted options into 26,187 shares and covered exercise/tax liability with 10,201 shares, increasing direct ownership by 9% to 197,847 units (SEC Form 4) (for tax liability)4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
HIMS FAQ
7 questionsWhat does Hims & Hers Health Inc. do?
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin...Where does HIMS stock trade?
Hims & Hers Health Inc. (HIMS) is listed on NYSE.What sector and industry is HIMS in?
Hims & Hers Health Inc. operates in the Health Care sector, Medical/Nursing Services industry.When did Hims & Hers Health Inc. go public?
Hims & Hers Health Inc. (HIMS) completed its IPO in 2019.What are analysts saying about HIMS?
Hims & Hers Health Inc. has had 8 recent analyst actions on file. The most recent action was from Analyst: Neutral with a $3200.00 price target on 2026-09-11. Recent price targets range from $2300.00 to $3500.00.What companies are similar to HIMS?
Notable peers in the same industry include BTSG (BrightSpring Health Services Inc.), CHE (Chemed Corp), LFST (LifeStance Health Group Inc.), OPCH (Option Care Health Inc.), AMED (Amedisys Inc). Compare HIMS side-by-side with any of them on Quantisnow.How can I track HIMS on Quantisnow?
Quantisnow aggregates Hims & Hers Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HIMS to receive live email and push alerts on every new disclosure.